FDA.reportPublic FDA data

OXLUMO 94.5 MG in 0.5 ML Injection

RxCUI
2467158
RxNorm name
OXLUMO 94.5 MG in 0.5 ML Injection
Display name
OXLUMO 94.5 MG in 0.5 ML Injection
Full name
OXLUMO 94.5 MG in 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OXLUMOLUMASIRANAlnylam Pharmaceuticals, Inc.16985a31-f5e4-4557-9266-fc78d4bc50552025-12-01Adverse reactionsExact identifier
rxcui: 2467158

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
16985a31-f5e4-4557-9266-fc78d4bc5055OXLUMO 94.5 MG in 0.5 ML Injection [PSN] · 0.5 ML lumasiran 189 MG/ML Injection [Oxlumo] [SBD] · 0.5 ML Oxlumo 189 MG/ML Injection [SY] · Oxlumo 94.5 MG (as lumasiran sodium 100 MG) per 0.5 ML Injection [SY] · Oxlumo 94.5 MG per 0.5 ML Injection [SY]59These highlights do not include all the information needed to use OXLUMO ® safely and effectively. See full prescribing information for OXLUMO. OXLUMO (lumasiran) injection, for subcutaneous use Initial U.S. Approval: 202020251201